Strength and endurance training lead to different post exercise glucose profiles in diabetic participants using a continuous subcutaneous glucose monitoring system

被引:53
作者
Cauza, E
Hanusch-Enserer, U
Strasser, B
Kostner, K
Dunky, A
Haber, P
机构
[1] Wilhelminenspital Stadt Wien, Dept Internal Med 5, A-1160 Vienna, Austria
[2] Med Univ, Dept Internal Med 4, Div Sports Med, Vienna, Austria
[3] Univ Queensland, Princess Alexandra Hosp, Dept Med, Brisbane, Qld 4102, Australia
[4] Wilhelminenspital Stadt Wien, Dept Diabet & Rheumatol, A-1160 Vienna, Austria
关键词
continuous subcutaneous glucose monitoring system; strength and endurance training; type 2 diabetes mellitus;
D O I
10.1111/j.1365-2362.2005.01573.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Although both strength training (ST) and endurance training (ET) seem to be beneficial in type 2 diabetes mellitus (T2D), little is known about post-exercise glucose profiles. The objective of the study was to report changes in blood glucose (BG) values after a 4-month ET and ST programme now that a device for continuous glucose monitoring has become available. Materials and methods Fifteen participants, comprising four men age 56.5 +/- 0.9 years and 11 women age 57.4 +/- 0.9 years with T2D, were monitored with the MiniMed (Northridge, CA, USA) continuous glucose monitoring system (CGMS) for 48 h before and after 4 months of ET or ST. The ST consisted of three sets at the beginning, increasing to six sets per week at the end of the training period, including all major muscle groups and ET performed with an intensity of maximal oxygen uptake of 60% and a volume beginning at 15 min and advancing to a maximum of 30 min three times a week. Results A total of 17 549 single BG measurements pretraining (619.7 +/- 39.8) and post-training (550.3 +/- 30.1) were recorded, correlating to an average of 585 +/- 25.3 potential measurements per participant at the beginning and at the end of the study. The change in BG-value between the beginning (132 mg dL(-1)) and the end (118 mg dL(-1)) for all participants was significant (P = 0.028). The improvement in BG-value for the ST programme was significant (P = 0.02) but for the ET no significant change was measured (P = 0.48). Glycaemic control improved in the ST group and the mean BG was reduced by 15.6% (Cl 3-25%). Conclusion In conclusion, the CGMS may be a useful tool in monitoring improvements in glycaemic control after different exercise programmes. Additionally, the CGMS may help to identify asymptomatic hypoglycaemia or hyperglycaemia after training programmes.
引用
收藏
页码:745 / 751
页数:7
相关论文
共 23 条
[11]   Walking for exercise - immediate effect on blood glucose levels in type 2 diabetes [J].
Fritz, T ;
Rosenqvist, U .
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2001, 19 (01) :31-33
[12]  
Gross T M, 2000, Diabetes Technol Ther, V2, P49, DOI 10.1089/152091500316737
[13]   Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs [J].
Guerci, B ;
Floriot, M ;
Böhme, P ;
Durain, D ;
Benichou, M ;
Jellimann, S ;
Drouin, P .
DIABETES CARE, 2003, 26 (03) :582-589
[14]  
Hay L C, 2003, Diabetes Technol Ther, V5, P19, DOI 10.1089/152091503763816427
[15]   Nocturnal hypoglycemia detected with the Continuous Glucose Monitoring System in pediatric patients with type 1 diabetes [J].
Kaufman, FR ;
Austin, J ;
Neinstein, A ;
Jeng, L ;
Halvorson, M ;
Devoe, DJ ;
Pitukcheewanont, P .
JOURNAL OF PEDIATRICS, 2002, 141 (05) :625-630
[16]   A pilot study of the continuous glucose monitoring system - Clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects [J].
Kaufman, FR ;
Gibson, LC ;
Halvorson, M ;
Carpenter, S ;
Fisher, LK ;
Pitukcheewanont, P .
DIABETES CARE, 2001, 24 (12) :2030-2034
[17]   Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type I diabetes [J].
McGowan, K ;
Thomas, W ;
Moran, A .
DIABETES CARE, 2002, 25 (09) :1499-1503
[18]   Reproducibility of glucose measurements using the glucose sensor [J].
Metzger, M ;
Leibowitz, G ;
Wainstein, J ;
Glaser, B ;
Raz, I .
DIABETES CARE, 2002, 25 (07) :1185-1191
[19]   Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring [J].
Rebrin, K ;
Steil, GM ;
Van Antwerp, WP ;
Mastrototaro, JJ .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 277 (03) :E561-E571
[20]  
Tsalikian E, 2004, DIABETES CARE, V27, P722